SCIENCE TIMES 6. Gilard V, Djoubairou BO, Lepetit A, et al. progressed. In this study, the patient was reported. This response continued Small versus large catheters for ventriculostomy in the underwent surgical resection of 3 out of for 7.5 mo after initiation of CAR T-cell management of intraventricular hemorrhage. World 5 progressive tumors. A Rickham catheter therapy. However, the tumor eventually Neurosurg. 2017;97:117-122. was placed into the resection cavity of one recurred at 4 intracranial sites that were 7. Honeybul S, Ho KM, Gillett G. Outcome following decompressive hemicraniectomy for malignant of the tumors through which the patient different and non-adjacent to initial cerebral infarction: ethical considerations. Stroke. received 6 cycles of autologous CAR T- tumors. 2015;46(9):2695-2698. 6 3 cells (2–10 × 10 cells/infusion) that had The paper by Brown et al provides been modified to target the IL13Rα2. proof of concept for utilizing CAR T- The patient received 10 further doses cells in GBM. The route of delivery was Use of Chimeric Antigen through an intraventricular catheter after 2 shown to be important as intracavitary nonresected lesions continued to progress infusion appeared to act locally while Receptor T Cells as a and 2 new lesions appeared. Cerebrospinal intraventricular
Neurosurgery – Oxford University Press
Published: May 1, 2017
It’s your single place to instantly
discover and read the research
that matters to you.
Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.
All for just $49/month
Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly
Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.
Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.
Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.
All the latest content is available, no embargo periods.
“Hi guys, I cannot tell you how much I love this resource. Incredible. I really believe you've hit the nail on the head with this site in regards to solving the research-purchase issue.”Daniel C.
“Whoa! It’s like Spotify but for academic articles.”@Phil_Robichaud
“I must say, @deepdyve is a fabulous solution to the independent researcher's problem of #access to #information.”@deepthiw
“My last article couldn't be possible without the platform @deepdyve that makes journal papers cheaper.”@JoseServera